JP Morgan Securities Plc, as the sole financial adviser to Concord Chorus Limited, made a public dealing disclosure related to Hipgnosis Songs Fund Limited. The disclosure, made on 29th April 2024, included details of purchases and sales of ordinary shares, as well as cash-settled derivative transactions. The purchases and sales of ordinary shares totaled 9,021,994 and 8,198,847, respectively, with the highest price per unit paid at 1.0387 GBP and the lowest at 1.0250 GBP.

Additionally, the disclosure included cash-settled derivative transactions, such as equity swaps, with details of opening and closing long/short positions and the associated prices per unit. The disclosure also mentioned stock-settled derivative transactions, including options, but no specific details were provided. Furthermore, the disclosure stated that there were no indemnity or other dealing arrangements, agreements, arrangements, or understandings relating to options or derivatives.

The disclosure was made in accordance with Rule 8 of the Takeover Code and was addressed to a Regulatory Information Service. For any further consultation regarding the Code's dealing disclosure requirements, the Panel's Market Surveillance Unit was made available.

This disclosure provides insight into the recent dealings and transactions involving Hipgnosis Songs Fund Limited's securities, shedding light on the activities of JP Morgan Securities Plc as the exempt principal trader in this context.